Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain
Clinical trial NCT05598736 · UNKNOWN
Trial details
- NCT number
- NCT05598736
- Sponsor
- Otivio AS
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-04
- Primary completion
- 2023-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.